Tenenbaum, A., & Fisman, E. Z. (2004). Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: Fibrates, statins or both? BioMed Central.
シカゴスタイル引用形Tenenbaum, Alexander, , Enrique Z. Fisman. Which Is the Best Lipid-modifying Strategy in Metabolic Syndrome and Diabetes: Fibrates, Statins or Both? BioMed Central, 2004.
MLA引用形式Tenenbaum, Alexander, , Enrique Z. Fisman. Which Is the Best Lipid-modifying Strategy in Metabolic Syndrome and Diabetes: Fibrates, Statins or Both? BioMed Central, 2004.
警告: この引用は必ずしも正確ではありません.